false 0001676047 0001676047 2024-05-15 2024-05-15 0001676047 us-gaap:CommonStockMember 2024-05-15 2024-05-15 0001676047 NTRB:WarrantsMember 2024-05-15 2024-05-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549 

 

 FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 15, 2024

 

Nutriband Inc.

 

Nevada   001-40854   81-1118176

(State or Other Jurisdiction

 of Incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

121 S. Orange Ave. Suite 1500

Orlando, Florida

  32801
(Address of Principal Executive Offices)   (Zip Code)

 

(407) 377-6695

Registrant’s Telephone Number, Including Area Code

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Securities registered pursuant to Section 12(b) of the Act:

 Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock    NTRB    The Nasdaq Stock Market LLC 
Warrants   NTRBW   The Nasdaq Stock Market LLC

 

 

 

 

 

Item 5.02. Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.

 

On May 15, 2024, the Board of directors of the Company appointed Sergei Glinka as a director of the Company. Mr. Glinka, age 58, since 2019 has been the Commercial Manager of TG Biochemicals Limited, Cyprus. Since 2019, he has been a member of the Board of GST Investments OÜ, Estonia. Commencing in 1973 Mr. Glinka attended secondary school in Moldova, graduating in 1981, and graduated from the Tallinn Merchant Marine School, Estonia, in 1986.

 

 

 

SIGNATURES

 

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

 

 

   NUTRIBAND, INC.
     
Date: May 16, 2024 By:  /s/ Gareth Sheridan
  R: Gareth Sheridan
  Chief Executive Officer